C HEALTH GP (08225) announced its performance for the year 2025, with a net loss of 1496.2 million yuan, an increase of 3.1% year-on-year.
Chinese Medical Group (08225) announced its annual performance for the year ended December 31, 2025, with revenue of RMB 28.564 million, a year-on-year increase of 8.0%; a net loss of RMB 14.962 million, a year-on-year expansion of 3.1%; and a basic loss per share of 1.5 cents.
C HEALTH GP (08225) announced its annual performance ending on December 31, 2025, with a operating income of 28.564 million yuan, a year-on-year increase of 8.0%; a net loss of 14.962 million yuan, a year-on-year expansion of 3.1%; basic loss per share of 1.5 cents.
Related Articles

BBSB INTL (08610) reported an annual net profit attributable to shareholders of 6.289 million Ringgit, a decrease of 75.99% year-on-year.

XINHUA LANDE (08106) releases its financial performance for the year 2025, with a net profit of 108.7 million yuan.

Yik Wo International (08659) announces financial performance for 2025. The attributable loss for the year is expected to be approximately 6.773 million yuan, a year-on-year change from profit to loss.
BBSB INTL (08610) reported an annual net profit attributable to shareholders of 6.289 million Ringgit, a decrease of 75.99% year-on-year.

XINHUA LANDE (08106) releases its financial performance for the year 2025, with a net profit of 108.7 million yuan.

Yik Wo International (08659) announces financial performance for 2025. The attributable loss for the year is expected to be approximately 6.773 million yuan, a year-on-year change from profit to loss.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


